223 related articles for article (PubMed ID: 27189774)
1. Zolpidem Mucoadhesive Formulations for Intranasal Delivery: Characterization, In Vitro Permeability, Pharmacokinetics, and Nasal Ciliotoxicity in Rats.
Wang Y; Li M; Qian S; Zhang Q; Zhou L; Zuo Z; Lee B; Toh M; Ho T
J Pharm Sci; 2016 Sep; 105(9):2840-2847. PubMed ID: 27189774
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin.
Trapani G; Lopedota A; Boghetich G; Latrofa A; Franco M; Sanna E; Liso G
Int J Pharm; 2003 Dec; 268(1-2):47-57. PubMed ID: 14643976
[TBL] [Abstract][Full Text] [Related]
3. Development of a cyclodextrin-based nasal delivery system for lorazepam.
Jug M; Bećirević-Laćan M
Drug Dev Ind Pharm; 2008 Aug; 34(8):817-26. PubMed ID: 18622800
[TBL] [Abstract][Full Text] [Related]
4. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
Shah B; Khunt D; Misra M; Padh H
Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
[TBL] [Abstract][Full Text] [Related]
5. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.
Greenblatt DJ; Harmatz JS; Roth T; Singh NN; Moline ML; Harris SC; Kapil RP
Clin Ther; 2013 May; 35(5):604-11. PubMed ID: 23541711
[TBL] [Abstract][Full Text] [Related]
7. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
[TBL] [Abstract][Full Text] [Related]
8. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
[TBL] [Abstract][Full Text] [Related]
9. Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles.
Bartos C; Ambrus R; Sipos P; Budai-Szűcs M; Csányi E; Gáspár R; Márki Á; Seres AB; Sztojkov-Ivanov A; Horváth T; Szabó-Révész P
Int J Pharm; 2015 Aug; 491(1-2):198-207. PubMed ID: 26142244
[TBL] [Abstract][Full Text] [Related]
10. Thiolated hydroxypropyl-β-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation.
Laquintana V; Asim MH; Lopedota A; Cutrignelli A; Lopalco A; Franco M; Bernkop-Schnürch A; Denora N
Int J Pharm; 2019 Dec; 572():118820. PubMed ID: 31706864
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a Novel Zolpidem Nasal Spray for Rapid Management of Insomnia: First Trial in Humans.
Li CT; Su TP; Wang Y; Lee B; Toh M; Ho T
J Clin Sleep Med; 2016 Nov; 12(11):1453-1459. PubMed ID: 27568900
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive microspheres for nasal administration of cyclodextrins.
Gavini E; Rassu G; Haukvik T; Lanni C; Racchi M; Giunchedi P
J Drug Target; 2009 Feb; 17(2):168-79. PubMed ID: 18985506
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of nano-based films for buccal delivery of zolpidem.
Al-Dhubiab BE
Braz Oral Res; 2016 Nov; 30(1):e126. PubMed ID: 27901207
[TBL] [Abstract][Full Text] [Related]
14. Development of a Novel Oral Cavity Compartmental Absorption and Transit Model for Sublingual Administration: Illustration with Zolpidem.
Xia B; Yang Z; Zhou H; Lukacova V; Zhu W; Milewski M; Kesisoglou F
AAPS J; 2015 May; 17(3):631-42. PubMed ID: 25716146
[TBL] [Abstract][Full Text] [Related]
15. Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery.
Racaniello GF; Laquintana V; Summonte S; Lopedota A; Cutrignelli A; Lopalco A; Franco M; Bernkop-Schnürch A; Denora N
Int J Pharm; 2021 Jun; 603():120728. PubMed ID: 34029665
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic effects of simultaneous administration of single-dose gabapentin 500 mg and zolpidem tartrate 10 mg in healthy volunteers: a randomized, open-label, crossover trial.
Galitz LA; Jayawardena S; Furey SA
Drugs R D; 2015 Mar; 15(1):71-7. PubMed ID: 25567214
[TBL] [Abstract][Full Text] [Related]
18. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
19. Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets.
Greenblatt DJ; Harmatz JS; Singh NN; Roth T; Harris SC; Kapil RP
J Clin Pharmacol; 2013 Nov; 53(11):1194-8. PubMed ID: 23939537
[TBL] [Abstract][Full Text] [Related]
20. Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties.
Blumer JL; Reed MD; Steinberg F; O'Riordan MA; Rosen CL; Springer MA; Christensen M; Glaze D;
Clin Pharmacol Ther; 2008 Apr; 83(4):551-8. PubMed ID: 17957186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
